# Arcturus Therapeutics Holdings Inc.: filings

ARCT · Nasdaq · CIK 1768224 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arct.md) · [Financials](/companies/arct/financials.md) · [Filings](/companies/arct/filings.md) · [Insiders](/companies/arct/insiders.md)

## Reports and events: 141 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 134, 8-K 102, 10-Q 22, SC 13G/A 18, 144 14, 424B5 11, SCHEDULE 13G/A 11, 3 10, SC 13G 10, DEF 14A 9, 10-K 7, S-8 6, CORRESP 5, EFFECT 5, S-3 5, UPLOAD 4, NT 10-Q 2, S-3/A 2, SEC STAFF LETTER 2, 424B3 1, 4/A 1, 8-K12B 1, 8-K/A 1, CT ORDER 1, DEFR14A 1, DEL AM 1, PRE 14A 1, S-3ASR 1, S-3MEF 1, S-4 1, S-4/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 16:11 ET | [8-K](/filings/0001193805-26-001277.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-001277 |
| 2026-08-25 | 06:00 ET | [8-K](/filings/0001193805-26-001130.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-001130 |
| 2026-08-06 | 16:19 ET | [10-Q](/filings/0001193125-26-338090.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338090 |
| 2026-08-06 | 16:06 ET | [8-K](/filings/0001193805-26-001039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-26-001039 |
| 2026-07-02 | 07:05 ET | [8-K](/filings/0001193805-26-000910.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000910 |
| 2026-06-05 | 17:20 ET | [8-K](/filings/0001193805-26-000770.md) | 5.07 Shareholder vote results | 0001193805-26-000770 |
| 2026-05-07 | 16:14 ET | [10-Q](/filings/0001193125-26-211943.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211943 |
| 2026-05-07 | 16:08 ET | [8-K](/filings/0001193805-26-000573.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000573 |
| 2026-04-24 | 16:05 ET | [DEF 14A](/filings/0001193805-26-000507.md) | Proxy statement, period 2026-06-05 | 0001193805-26-000507 |
| 2026-03-03 | 16:34 ET | [10-K](/filings/0001193125-26-088391.md) | Annual report, period 2025-12-31 | 0001193125-26-088391 |
| 2026-03-03 | 16:05 ET | [8-K](/filings/0001193805-26-000214.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-26-000214 |
| 2025-12-15 | 08:30 ET | [8-K](/filings/0001193805-25-001734.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-25-001734 |
| 2025-11-12 | 06:25 ET | [10-Q](/filings/0001193125-25-275758.md) | Quarterly report, period 2025-09-30 | 0001193125-25-275758 |
| 2025-11-10 | 16:09 ET | [8-K](/filings/0001193805-25-001555.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-001555 |
| 2025-10-22 | 07:50 ET | [8-K](/filings/0001193805-25-001499.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-001499 |
| 2025-09-26 | 06:01 ET | [8-K](/filings/0001193805-25-001368.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-001368 |
| 2025-08-29 | 06:00 ET | [8-K](/filings/0001193805-25-001247.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-001247 |
| 2025-08-11 | 16:14 ET | [10-Q](/filings/0000950170-25-106560.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106560 |
| 2025-08-11 | 16:01 ET | [8-K](/filings/0001193805-25-001175.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-001175 |
| 2025-06-30 | 16:05 ET | [8-K](/filings/0001193805-25-000946.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-000946 |
| 2025-06-06 | 16:05 ET | [8-K](/filings/0001193805-25-000820.md) | 5.07 Shareholder vote results | 0001193805-25-000820 |
| 2025-05-12 | 16:11 ET | [10-Q](/filings/0000950170-25-069210.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069210 |
| 2025-05-12 | 16:05 ET | [8-K](/filings/0001193805-25-000630.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-000630 |
| 2025-04-25 | 17:15 ET | [DEF 14A](/filings/0001193805-25-000561.md) | Proxy statement, period 2025-06-06 | 0001193805-25-000561 |
| 2025-03-06 | 16:39 ET | [10-K](/filings/0000950170-25-034787.md) | Annual report, period 2024-12-31 | 0000950170-25-034787 |
| 2025-03-06 | 16:02 ET | [8-K](/filings/0001193805-25-000275.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-000275 |
| 2024-11-07 | 16:58 ET | [10-Q](/filings/0000950170-24-123469.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123469 |
| 2024-11-07 | 16:25 ET | [8-K](/filings/0001193805-24-001318.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-001318 |
| 2024-08-13 | 07:54 ET | [8-K](/filings/0001193805-24-001023.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-24-001023 |
| 2024-08-05 | 16:50 ET | [10-Q](/filings/0000950170-24-090905.md) | Quarterly report, period 2024-06-30 | 0000950170-24-090905 |
| 2024-08-05 | 16:09 ET | [8-K](/filings/0001193805-24-000990.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-000990 |
| 2024-06-24 | 16:07 ET | [8-K](/filings/0001193805-24-000842.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-24-000842 |
| 2024-06-14 | 16:30 ET | [8-K](/filings/0001193805-24-000806.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193805-24-000806 |
| 2024-05-08 | 16:17 ET | [10-Q](/filings/0000950170-24-055702.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055702 |
| 2024-05-08 | 16:05 ET | [8-K](/filings/0001193805-24-000614.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-000614 |
| 2024-04-29 | 16:05 ET | [DEF 14A](/filings/0001193805-24-000574.md) | Proxy statement, period 2024-06-14 | 0001193805-24-000574 |
| 2024-04-05 | 17:00 ET | [8-K](/filings/0001193805-24-000505.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193805-24-000505 |
| 2024-03-19 | 06:00 ET | [8-K](/filings/0001193805-24-000392.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-24-000392 |
| 2024-03-14 | 09:09 ET | [10-K](/filings/0000950170-24-031156.md) | Annual report, period 2023-12-31 | 0000950170-24-031156 |
| 2024-03-14 | 09:05 ET | [8-K/A](/filings/0001193805-24-000364.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-000364 |
| 2024-03-07 | 16:05 ET | [8-K](/filings/0001193805-24-000335.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-24-000335 |
| 2024-02-23 | 16:05 ET | [8-K](/filings/0001193805-24-000264.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-24-000264 |
| 2023-11-14 | 16:34 ET | [10-Q](/filings/0000950170-23-063778.md) | Quarterly report, period 2023-09-30 | 0000950170-23-063778 |
| 2023-11-14 | 16:10 ET | [8-K](/filings/0001193805-23-001493.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-23-001493 |
| 2023-09-26 | 16:06 ET | [8-K](/filings/0001193805-23-001328.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-23-001328 |
| 2023-08-14 | 16:06 ET | [8-K](/filings/0001193805-23-001174.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-23-001174 |
| 2023-08-07 | 17:02 ET | [10-Q](/filings/0000950170-23-039149.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039149 |
| 2023-08-07 | 16:23 ET | [8-K](/filings/0001193805-23-001112.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-23-001112 |
| 2023-07-14 | 07:53 ET | [8-K](/filings/0001193805-23-000984.md) | 7.01 Regulation FD disclosure | 0001193805-23-000984 |
| 2023-06-30 | 08:28 ET | [8-K](/filings/0001193805-23-000929.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-23-000929 |

Page 1 of 3. [Older](/companies/arct/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 06:06 ET. No prices; not investment advice.